On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their …
![KangaBio KGX101: Revolutionizing Cancer Therapy](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-cottonbro-studio-3952241.jpg?resize=760%2C427&ssl=1)
![KangaBio KGX101: Revolutionizing Cancer Therapy](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-cottonbro-studio-3952241.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their …
Today, Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- …